GEODE CAPITAL MANAGEMENT, LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,731,954
+$4,572,304 QoQ
Shares Held
2,210,932
+2.1% QoQ
Ownership
1.99%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,630,059,403 across 67 Drug Manufacturers - Specialty & Generic names. AMLX ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
11,349,248 | $1,341,594,605 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,233,029 | $731,161,535 | |
| 3 | VTRS |
Viatris Inc
|
31,846,107 | $430,240,905 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,564,988 | $318,217,437 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,136,672 | $281,485,168 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,192,404 | $267,834,227 | |
| 7 | ALKS |
Alkermes plc.
|
4,182,267 | $147,884,960 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,765,952 | $133,947,458 |
All Filings in AMLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,731,954 | 2,210,932 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,159,650 | 2,165,534 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $24,625,609 | 1,812,039 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $10,848,366 | 1,692,413 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,853,809 | 806,161 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,146,672 | 567,903 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,785,366 | 551,039 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $890,844 | 468,866 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,028,135 | 1,066,245 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $15,172,139 | 1,030,716 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,981,665 | 982,068 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $20,232,595 | 937,997 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,141,411 | 890,982 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $31,552,085 | 853,913 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,890,901 | 635,556 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,457,091 | 231,417 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,443,427 | 190,150 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||